Garijo visit Chongqing, China, 2024. Belén Garijo (born 1960) is a Spanish business executive. Since May 2021, she has been the CEO and chair of the executive board of Merck Group. [1] [2]

Since becoming Chair of the Executive Board and CEO of Merck in May 2021, Belén Garijo has led a business transformation to strengthen the company's position as a global science and technology leader.

In May of 2021, Bélen Garijo became the chair of the executive board and CEO for Merck KGaA, the parent company of healthcare giant Merck.

Belén Garijo López (Almansa, Albacete, 31 de julio de 1960) es una médica y directora ejecutiva española. Es la CEO global del grupo farmacéutico alemán Merck . Es consejera del BBVA y del grupo francés L'Oréal .

Since becoming Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany in May 2021, Belén Garijo has led a business transformation to strengthen the company's position as a global science and technology leader.

Belén Garijo joined Merck in 2011 as chief operating officer of its biopharma division. She swiftly rose the ranks to CEO of its health care business sector in 2015, before taking the...

Before taking her current office in May 2021, Belén Garijo served as Vice-Chair of the Executive Board and Deputy CEO. Under her leadership of the Healthcare business, Merck became a key global player in oncology, immunology, and immuno-oncology.

Garijo leads Merck KGaA, a global drug and sciences company with $23 billion in annual sales and a history that dates back to 1668—not to be confused with U.S. pharma giant Merck.

Belén Garijo was promoted to CEO at German pharma company Merck KGaA in March 2021, making her the first woman to solely run a company listed on Germany’s DAX 30 index.